ArticleDiscover oncology2026
Uterine carcinosarcoma with concurrent right nephrolithiasis case report.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimUterine carcinosarcoma (UCS) is a rare and highly invasive gynecological malignancy with insidious clinical manifestations, particularly in underdeveloped regions where patients often neglect routine health screenings, missing the optimal opportunity for early intervention. This report aims to enhance the understanding of UCS by presenting the diagnosis and treatment process of a case. CASE PRESENTATION: A 57-year-old woman with right lumbar pain underwent B-ultrasound at a local health center, which identified a right renal stone. During the abdominal examination, a palpable mass was noted in the right lower abdomen. An magnetic resonance imaging (MRI) performed at our hospital revealed a large, irregular mass in the pelvic cavity, showing mixed abnormal signal intensity, measuring approximately 100 mm × 50 mm × 40 mm (left-right × anterior-posterior × craniocaudal diameter). Histopathological analysis of the resected tissue confirmed uterine carcinosarcoma.
conclusionUCS is a rare and highly aggressive malignancy. Owing to its subtle early clinical manifestations, it is frequently diagnosed at intermediate or advanced stages. Early detection and timely treatment are critical for improving patient outcomes. Raising awareness of the importance of regular health check-ups among postmenopausal women is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.